Major Step Forward In Cell Reprogramming; Closer To Making Safe Patient-Specific Stem Cells, Harvard Stem Cell Institute Researchers Report
Harvard Science -- A team of Harvard Stem Cell Institute (HSCI) researchers has made a major advance toward producing induced pluripotent stem cells, or iPS cells, that are safe enough to use in treating diseases in patients.